GS-0272 / Gilead - LARVOL DELTA

MARASLE: Study of GS-0272 in Participants With Rheumatoid Arthritis (clinicaltrials.gov) - P1 | N=87 | Recruiting | Sponsor: Gilead Sciences | Trial completion date: Jun 2025 ➔ Mar 2026 | Trial primary completion date: Jun 2025 ➔ Mar 2026

Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology

First domestic clinical trial of new autoimmune disease treatment [Google translation] (Health Korea News) - "On the 17th, the Ministry of Food and Drug Safety approved the phase 1b clinical trial plan (IND) for Gilead Sciences Korea's 'GS-0272'. The trial will evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamics of multiple ascending doses of 'GS-0272' in adult participants with rheumatoid arthritis....For reference, the domestic phase 1b clinical trial of 'GS-0272' is scheduled to be conducted at Chungnam National University Hospital, Seoul National University Hospital, and Ajou University Hospital until June next year."

Trial status • Rheumatoid Arthritis

MARASLE: Study of GS-0272 in Participants With Rheumatoid Arthritis (clinicaltrials.gov) - P1 | N=87 | Recruiting | Sponsor: Gilead Sciences | N=48 ➔ 87

Enrollment change • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology

MARASLE: Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus (clinicaltrials.gov) - P1 | N=48 | Recruiting | Sponsor: Gilead Sciences

Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus

MARASLE: Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus (clinicaltrials.gov) - P1 | N=48 | Recruiting | Sponsor: Gilead Sciences | Phase classification: P1b ➔ P1

Phase classification • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus

MARASLE: Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus (clinicaltrials.gov) - P1b | N=48 | Recruiting | Sponsor: Gilead Sciences | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus

MARASLE: Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus (clinicaltrials.gov) - P1b | N=48 | Not yet recruiting | Sponsor: Gilead Sciences

New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus